NSC |
Compound |
Enrichment |
Correlation |
NSC 703784 |
L-Lysinamide, N-[4-(1,3-benzothiazol-2-yl)phenyl-2-chlorophenyl]-,dihydrochloride |
0.0348993771550531 |
0.053520636 |
NSC 709358 |
1H-Pyrrole-2-carboxamide, N-[3-(dimethylamino)propyl]-1-methyl-4-[[[1-methyl- 4-[[1-oxo-4-[[(2,3,5,11a-tetrahydro-7-methoxy-5-oxo- 1H-pyrrolo[2,1-c][1,4]benzodiazepin-8-yl]oxy]butyl]amino]- 1H-pyrrol |
0.0348993771550531 |
0.34109792 |
NSC 710326 |
Null |
0.0348993771550531 |
0.33122134 |
NSC 717468 |
Null |
0.0348993771550531 |
0.21026514 |
NSC 724783 |
[1,5-dimethyl-10-(trifluoromethyl)-11,14,15,16-tetraoxatetra cyclo[10.3.1.04,13.08,13]hexadec-9-en-9-yl]-N,N-bis{[1,5-dim ethyl-10-(trifluoromethyl)-11,14,15,16-tetraoxatetracyclo[10 .3.1.04,13.08,13 |
0.0348993771550531 |
0.24000098 |
NSC 743433 |
8-(4-{4-[6-(4-piperazinoquinazoline)-7-methoxy-2,3,5,11-atetrahydra-1H-benzo[e]pyrrolo[1,2-c][1,4]diazepin-5-one |
0.0348993771550531 |
0.27290827 |
NSC 743695 |
Null |
0.0348993771550531 |
0.32677972 |
NSC 758670 |
TANNIC ACID |
0.0348993771550531 |
0.30497997 |
NSC 621335 |
Null |
0.0350615470435428 |
0.099085142 |
NSC 669349 |
Null |
0.0350615470435428 |
0.065494554 |